UK markets closed

Milestone Scientific, Inc. (MLSS)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.5600-0.0100 (-1.75%)
At close: 03:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 42.90M
Enterprise value 37.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.15
Price/book (mrq)5.35
Enterprise value/revenue 3.80
Enterprise value/EBITDA -5.37

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-24.32%
S&P500 52-week change 322.36%
52-week high 31.3500
52-week low 30.5200
50-day moving average 30.6534
200-day moving average 30.8079

Share statistics

Avg vol (3-month) 380.13k
Avg vol (10-day) 373.74k
Shares outstanding 576.6M
Implied shares outstanding 676.6M
Float 850.87M
% held by insiders 115.12%
% held by institutions 15.66%
Shares short (15 Apr 2024) 4379.38k
Short ratio (15 Apr 2024) 43.72
Short % of float (15 Apr 2024) 40.61%
Short % of shares outstanding (15 Apr 2024) 40.50%
Shares short (prior month 15 Mar 2024) 4425.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 314 Jan 2004

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -70.51%
Operating margin (ttm)-87.57%

Management effectiveness

Return on assets (ttm)-35.43%
Return on equity (ttm)-77.49%

Income statement

Revenue (ttm)9.83M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)0.90%
Gross profit (ttm)N/A
EBITDA -7.04M
Net income avi to common (ttm)-6.93M
Diluted EPS (ttm)-0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.95M
Total cash per share (mrq)0.08
Total debt (mrq)395.98k
Total debt/equity (mrq)4.94%
Current ratio (mrq)3.51
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-5.33M
Levered free cash flow (ttm)-3.23M